Longevity Health Holdings, Inc.

Longevity Health Holdings, Inc. is a bio-aesthetics company that develops, manufactures, and markets cosmetic skincare and haircare products. It uses Carmell Secretome and Elevai Exosomes to support skin and hair health. Carmell Secretome contains growth factors, proteins, and peptides extracted from allogeneic human platelets, while Elevai Exosomes contains growth factors, cytokines, peptides, and other small molecules involved in the body's natural healing process. The company also develops a microemulsion formulation that delivers lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. It has a licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Founded in 2008, it is headquartered in Pittsburgh, Pennsylvania.